Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

26
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
26
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

16
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
16
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

18
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
18
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

68
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
68
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

53
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

49
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Low-Cost Vision-GPS Framework for the Unified Mapping of Vertical and Horizontal Road Assets Using Deep Learning.

Sensors (Basel, Switzerland)·2026
Same author

<b>A new species of <i>Chonala</i> Moore, 1893 (Lepidoptera: Nymphalidae) from northeastern India</b>.

Zootaxa·2026
Same author

<b>Three new species of <i>Sarasaeschna</i> Karube & Yeh, 2001 (Odonata: Anisoptera: Aeshnidae) from northeastern India; with a new record of <i>Sarasaeschna</i> <i>khasiana</i> (Lieftinck, 1968)</b>.

Zootaxa·2026
Same author

<b>Six new species of <i>Calicnemia</i> Strand, 1926 and one new species of <i>Coeliccia</i> Kirby, 1890 (Odonata: Zygoptera: Platycnemididae) from northeastern India</b>.

Zootaxa·2026
Same author

SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism.

Renal failure·2026
Same author

Alcohol-associated liver disease in the MENA region: A 16-country survey of healthcare provider perspectives.

Annals of hepatology·2026

Related Experiment Video

Updated: Aug 18, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

509

IgA nephropathy pathogenesis and therapy: Review & updates.

Elmukhtar Habas1, Elrazi Ali2, Khalifa Farfar3

  • 1Hamad General Medicine, Doha, Qatar.

Medicine
|December 9, 2022
PubMed
Summary

IgA nephropathy (IgAN) is a common kidney disease. Proteinuria helps monitor IgAN progression and treatment effectiveness, with steroids as a primary therapy.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

766
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K

Related Experiment Videos

Last Updated: Aug 18, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

509
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

766
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K

Area of Science:

  • Nephrology
  • Immunology

Background:

  • IgA nephropathy (IgAN) is the most common primary glomerulonephritis.
  • It is a leading cause of end-stage renal disease, often presenting with hematuria.
  • Pathogenesis involves multifactorial autoimmune complex formation and inflammation.

Purpose of the Study:

  • To review current data and clinical updates on IgA nephropathy pathogenesis.
  • To explore various treatment strategies for IgAN.

Main Methods:

  • Comprehensive literature search across major scientific databases (PubMed, Google Scholar, Scopus, EMBASE).
  • Non-systematic clinical review of available data and clinical updates.

Main Results:

  • IgAN exhibits heterogeneous global patterns, complicating pathogenesis and treatment understanding.
  • Proteinuria is the key indicator for monitoring IgAN progression and treatment response.
  • Steroids are foundational, supplemented by other agents with variable efficacy.

Conclusions:

  • Effective IgAN management necessitates a collaborative approach between patients and physicians.
  • Kidney transplantation is recommended for IgAN patients, despite high recurrence rates.
  • Proteinuria monitoring is crucial for guiding IgAN treatment and assessing outcomes.